Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease.

Samuel Raimundo FernandesSónia BernardoSofia SaraivaAna Rita GonçalvesPaula Moura SantosAna ValenteLuís Araújo CorreiaHelena Cortez-Pinto Fernando Magro

Published in: United European gastroenterology journal (2023)

Tight-monitoring and reactive treatment escalation increase the rates of transmural remission in CD. Intervention in early disease further improves these results.

Keyphrases

randomized controlled trial
disease activity
blood brain barrier
systemic lupus erythematosus
ulcerative colitis
nk cells